Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
International Journal of Stroke : Official Journal of the International Stroke Society
|
April 28, 2025
Recurrent ischemic stroke in young adults: A multicenter cohort study, systematic review, and meta-analysis
Gabriel Yi Ren Kwok, Ryan Wei Rong Chen, Tasha Anna Leow, et al.
Neuroimage. Reports
|
September 27, 2024
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial
Thomas Williams, Nevin John, Alberto Calvi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2026
Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4
Sarah Wright, Vu C Dang, Sami Hussain, et al.
The Journal of Biological Chemistry
|
November 14, 2008
Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system
Kelly J Inglis, David Chereau, Elizabeth F Brigham, et al.
Frontiers in Public Health
|
October 22, 2024
Longitudinal wastewater-based surveillance of SARS-CoV-2 during 2023 in Ethiopia
Daniel Abera Dinssa, Gebremedhin Gebremicael, Yohannes Mengistu, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 30, 2010
Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration
Gary D Probst, Simeon Bowers, Jennifer M Sealy, et al.
Neurology
|
August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis
Sarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 5, 2011
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration
Simeon Bowers, Anh P Truong, R Jeffrey Neitz, et al.
European Journal of Neurology
|
April 10, 2025
European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)
Jalesh N Panicker, Alessandra Fanciulli, Magdalena Krbot Skoric, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
International Journal of Stroke : Official Journal of the International Stroke Society
|
April 28, 2025
Recurrent ischemic stroke in young adults: A multicenter cohort study, systematic review, and meta-analysis
Gabriel Yi Ren Kwok, Ryan Wei Rong Chen, Tasha Anna Leow, et al.
Neuroimage. Reports
|
September 27, 2024
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial
Thomas Williams, Nevin John, Alberto Calvi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2026
Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4
Sarah Wright, Vu C Dang, Sami Hussain, et al.
The Journal of Biological Chemistry
|
November 14, 2008
Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system
Kelly J Inglis, David Chereau, Elizabeth F Brigham, et al.
Frontiers in Public Health
|
October 22, 2024
Longitudinal wastewater-based surveillance of SARS-CoV-2 during 2023 in Ethiopia
Daniel Abera Dinssa, Gebremedhin Gebremicael, Yohannes Mengistu, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 30, 2010
Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration
Gary D Probst, Simeon Bowers, Jennifer M Sealy, et al.
Neurology
|
August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis
Sarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 5, 2011
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration
Simeon Bowers, Anh P Truong, R Jeffrey Neitz, et al.
European Journal of Neurology
|
April 10, 2025
European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)
Jalesh N Panicker, Alessandra Fanciulli, Magdalena Krbot Skoric, et al.
Page
of 10